FRANKLIN RESOURCES INC

Holdings History for Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)

Symbol: BNTC on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001
Latest Disclosed Shares Owned: 3,751,709 shares
Security Ownership %: 11%

Shares, Excluding Options vs Price

Value, Excluding Options

Franklin Resources, Inc. ownership in Benitec Biopharma Inc. Common Stock, par value $0.0001 (BNTC)

29 Jan 2026 - Franklin Resources, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,751,709 shares of Benitec Biopharma Inc. Common Stock, par value $0.0001 (BNTC). This represents 11% ownership of the company. In their previous filing dated 04 Nov 2025, FRANKLIN RESOURCES INC had reported owning 4,144,037 shares, indicating a decrease of +9.5%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Franklin Resources, Inc.	11%	-29%	$50,561,782	3,751,709	-392,328	-9.5%	$13.48	13G/A	31 Dec 2025	29 Jan 2026, 11:34
Franklin Resources, Inc.	15%	-8.8%	$58,140,839	4,144,037	-271,093	-6.1%	$14.03	13G/A	30 Sep 2025	04 Nov 2025, 11:49
Franklin Resources, Inc.	16%	-10%	$60,001,617	4,415,130	-78,561	-1.7%	$13.59	13G/A	31 Mar 2025	09 May 2025, 13:06
Franklin Resources, Inc.	18%	+20%	$61,069,261	4,493,691	+239	+0.01%	$13.59	13G/A	31 Dec 2024	27 Jan 2025, 12:51
Franklin Resources, Inc.	15%		$61,066,013	4,493,452			$13.59	13G/A	30 Sep 2024	07 Nov 2024, 12:30

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	-0%	$29,597,698	2,197,305	-392,328	-15%	$13.47	Q4 2025
30 Sep 2025	0.01%	-0%	$36,332,551	2,589,633	-111,810	-4.1%	$14.03	Q3 2025
30 Jun 2025	0.01%	-0%	$31,606,883	2,701,443	-159,283	-5.6%	$11.70	Q2 2025
31 Mar 2025	0.01%	-0%	$37,218,045	2,860,726	-78,561		$13.01	Q1 2025
31 Dec 2024	0.01%	+0.01%	$37,123,195	2,939,287	+2,142,643	+269%	$12.63	Q4 2024
30 Sep 2024	0%	0%	$8,093,903	796,644	0		$10.16	Q3 2024
30 Jun 2024	0%	+0%	$5,568,542	796,644	+208,334	+35%	$6.99	Q2 2024
31 Mar 2024	0%	0%	$3,012,147	588,310	+73	+0.01%	$5.12	Q1 2024
31 Dec 2023	0%	0%	$1,905,888	588,237	0		$3.24	Q4 2023
30 Sep 2023	0%	+0%	$1,776,476	588,237	+588,237	NEW	$3.02	Q3 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.